Victory Capital Management Inc Co Diagnostics, Inc. Transaction History

Victory Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$2.32 - $3.68 $88 - $139	38 Added 0.36%	10,667 $26,000
Q2 2022 Aug 01, 2022	SELL	$3.76 - $6.29 $2,665 - $4,459	-709 Reduced 6.25%	10,629 $60,000
Q1 2022 May 04, 2022	BUY	$5.03 - $9.61 $8,042 - $15,366	1,599 Added 16.42%	11,338 $70,000
Q4 2021 Feb 07, 2022	SELL	$8.12 - $10.37 $14,080 - $17,981	-1,734 Reduced 15.11%	9,739 $87,000
Q3 2021 Nov 02, 2021	SELL	$7.48 - $11.38 $8,863 - $13,485	-1,185 Reduced 9.36%	11,473 $112,000
Q2 2021 Aug 03, 2021	BUY	$7.16 - $9.56 $90,631 - $121,010	12,658 New	12,658 $104,000
Q2 2020 Aug 07, 2020	SELL	$7.46 - $23.42 $26,311 - $82,602	-3,527 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$0.91 - $17.81 $1,476 - $28,905	1,623 Added 85.24%	3,527 $27,000
Q4 2019 Feb 04, 2020	BUY	$0.88 - $1.12 $213 - $272	243 Added 14.63%	1,904 $6,000
Q3 2019 Nov 12, 2019	BUY	$0.81 - $1.35 $1,345 - $2,242	1,661 New	1,661 $2,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $26.3M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.